ABBLO PHARMA ApS: Financial statements 2022
CVR: 34080534
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,056,147 and a net result of DKK 300,769 compared with DKK 285,238 the year before. That is an increase of 42.6% compared with the year before. Equity in the 2022 report amounted to DKK -328,422. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,056,147
- Profit/Loss
- DKK 300,769
- Equity
- DKK -328,422
- Total Assets
- DKK 1,161,691
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.1 mio. | 301 t. | -328 t. | 1 |
| 2021 | - | 740 t. | 285 t. | -629 t. | 1 |
| 2020 | - | 376 t. | 214 t. | -914 t. | 1 |
| 2019 | - | 306 t. | 100 t. | -1.1 mio. | 1 |
| 2018 | - | 146 t. | 12 t. | -1.2 mio. | 1 |
Official annual report
Keep an eye on ABBLO PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ABBLO PHARMA ApS has published its annual report for 2021. Gross profit came to DKK 740,462, and the net result was DKK 285,238.
About ABBLO PHARMA ApS
ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The board consists of Mie Hjerrild Petersen (chair) and Nic Borch-Christensen. The company is owned by ABBLO S.à.r.l. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity in the 2025 report amounted to DKK -238,088.